Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-14-000006
Filing Date
2014-01-08
Accepted
2014-01-08 16:58:46
Documents
1
Period of Report
2014-01-06

Document Format Files

Seq Description Document Type Size
1 appy_faulkner.html 4  
1 appy_faulkner.xml 4 3850
  Complete submission text file 0001079973-14-000006.txt   5327
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 5964 LA PLACE COURT CARLSBAD CA 92008
Business Address
FAULKNER DARYL (Reporting) CIK: 0001203763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 14516951